Immunoreactivity of p53, Mdm2, p21WAF1/CIP1, Bcl-2, and Bax in Soft Tissue Sarcomas: Correlation With Histologic Grade

作者: Muna Sabah , Robert Cummins , Mary Leader , Elaine Kay

DOI: 10.1097/01.PAI.0000201809.43554.ED

关键词:

摘要: Tumor growth depends on 2 distinctive pathways: cell proliferation and apoptosis. The p53 pathway is an important regulator of the cycle as it triggers arrest or leads to apoptosis in response cellular stress therefore commonly targeted during tumorigenesis. Apoptosis also controlled by Bcl-2 family, which includes proapoptotic antiapoptotic proteins. aim this study was investigate expression proteins that are involved different types soft tissue sarcomas correlate these with histologic grade sarcoma cases. One hundred fifty-two cases were analyzed. consisted 54 low-grade, 40 intermediate-grade, 58 high-grade sarcomas. Immunohistochemical stains for p21(WAF1/CIP1), p53, Mdm2, Bcl-2, Bax carried out microarrays. Nuclear reactivity detected 49 (32.2%). Overexpression Mdm2 found 18 (11.8%) p21(WAF1/CIP1) immunostaining seen 28 tumors (18.4%). correlated tumor (low grade, 5.6% 3.7%; intermediate 22.5% 20%; high 63.8% 31%, respectively). Expression protein a common finding It 141 (92.8%). identified 59 (38.8%) more prevalent 25.9%; 32.5%; 55.2%). concluded alterations genes regulate events closely associated tumor, may be used prognostic markers.

参考文章(32)
Stefanou Dg, Briassoulis E, Pavlidis N, Nonni Av, Agnantis Nj, Athanassiadou Se, p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study. Anticancer Research. ,vol. 18, pp. 4673- 4681 ,(1998)
Maria Debiec-Rychter, Barbara Harezga-Bal, Piotr Rieske, Bogumil Olborski, Jacek Bartkowiak, Anna Szadowska, A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. Journal of Experimental & Clinical Cancer Research. ,vol. 18, pp. 403- 416 ,(1999)
Cristina R. Antonescu, Denis H. Leung, Maria Dudas, Marc Ladanyi, Murray Brennan, James M. Woodruff, Carlos Cordon-Cardo, Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. American Journal of Pathology. ,vol. 156, pp. 977- 983 ,(2000) , 10.1016/S0002-9440(10)64965-6
C Cordon-Cardo, Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. American Journal of Pathology. ,vol. 147, pp. 545- 560 ,(1995)
T. Vukosavljevic, C. Doglioni, T. Mentzel, C. D. M. Fletcher, S. Piccinin, A. P. Dei Tos, M. Boiocchi, Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. American Journal of Pathology. ,vol. 151, pp. 1531- 1539 ,(1997)
Takashi Tokino, Takashi Tokino, Bert Vogelstein, Kenneth W. Kinzler, David Sidransky, David E. Hill, Jonathan D. Oliner, Sharon Smith, Marilee Burrell, Fredrick S. Leach, Paul Meltzer, p53 Mutation and MDM2 Amplification in Human Soft Tissue Sarcomas Cancer Research. ,vol. 53, pp. 2231- 2234 ,(1993)
Sonya Y. Park, Sang In Shim, Byung Kee Kim, Jinyoung Yoo, Seok Jin Kang, Altered expression of G1 regulatory proteins in human soft tissue sarcomas. Archives of Pathology & Laboratory Medicine. ,vol. 126, pp. 567- 573 ,(2002) , 10.1043/0003-9985(2002)126<0567:AEOGRP>2.0.CO;2
Tomitaka Nakayama, Junya Toguchida, Bun-Ichiro Wadayama, Hiroshi Kanoe, Yoshihiko Kotoura, Masao S. Sasaki, MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. International Journal of Cancer. ,vol. 64, pp. 342- 346 ,(1995) , 10.1002/IJC.2910640511
Toshisada Adachi, Yoshinao Oda, Akio Sakamoto, Tsuyoshi Saito, Sadafumi Tamiya, Kouji Masuda, Masazumi Tsuneyoshi, Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component. International Journal of Surgical Pathology. ,vol. 9, pp. 99- 109 ,(2001) , 10.1177/106689690100900203